133 related articles for article (PubMed ID: 35487745)
1. Associations between physical activity prior to infection and COVID-19 disease severity and symptoms: results from the prospective Predi-COVID cohort study.
Malisoux L; Backes A; Fischer A; Aguayo G; Ollert M; Fagherazzi G
BMJ Open; 2022 Apr; 12(4):e057863. PubMed ID: 35487745
[TBL] [Abstract][Full Text] [Related]
2. Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study.
Fagherazzi G; Fischer A; Betsou F; Vaillant M; Ernens I; Masi S; Mossong J; Staub T; Brault D; Bahlawane C; Rashid MA; Ollert M; Gantenbein M; Huiart L
BMJ Open; 2020 Nov; 10(11):e041834. PubMed ID: 33234656
[TBL] [Abstract][Full Text] [Related]
3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management.
Abdolsalehi MR; Mahmoudi S; Badv RS; Pourakbari B; Mirnia K; Mahmoudieh Y; Mamishi S
Infect Disord Drug Targets; 2022; 22(1):e100821195494. PubMed ID: 35135466
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With COVID-19 Transmission Among US Air Force Trainees in a Congregant Setting.
Marcus JE; Frankel DN; Pawlak MT; Casey TM; Cybulski RJ; Enriquez E; Okulicz JF; Yun HC
JAMA Netw Open; 2021 Feb; 4(2):e210202. PubMed ID: 33630090
[TBL] [Abstract][Full Text] [Related]
7. Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study.
Elbéji A; Zhang L; Higa E; Fischer A; Despotovic V; Nazarov PV; Aguayo G; Fagherazzi G
BMJ Open; 2022 Nov; 12(11):e062463. PubMed ID: 36414294
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
9. Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: the UK experience.
Hull JH; Wootten M; Moghal M; Heron N; Martin R; Walsted ES; Biswas A; Loosemore M; Elliott N; Ranson C
Br J Sports Med; 2022 Jan; 56(1):4-11. PubMed ID: 34340972
[TBL] [Abstract][Full Text] [Related]
10. Elucidating symptoms of COVID-19 illness in the Arizona CoVHORT: a longitudinal cohort study.
Khan SM; Farland LV; Catalfamo CJ; Austhof E; Bell ML; Chen Z; Cordova-Marks F; Ernst KC; Garcia-Filion P; Heslin KM; Hoskinson J; Jehn ML; Joseph ECS; Kelley CP; Klimentidis Y; Russo Carroll S; Kohler LN; Pogreba-Brown K; Jacobs ET
BMJ Open; 2022 Jan; 12(1):e053403. PubMed ID: 35039294
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study.
Mittal J; Ghosh A; Bhatt SP; Anoop S; Ansari IA; Misra A
Diabetes Metab Syndr; 2021; 15(6):102302. PubMed ID: 34626924
[TBL] [Abstract][Full Text] [Related]
12. Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study.
Aguayo GA; Fischer A; Elbéji A; Linn N; Ollert M; Fagherazzi G
Front Public Health; 2023; 11():1055440. PubMed ID: 37006590
[TBL] [Abstract][Full Text] [Related]
13. Habitual physical activity and COVID-19.
Glace BW; Kremenic IJ; Hogan DE; Kwiecien SY; McHUGH MP
J Sports Med Phys Fitness; 2024 Jul; 64(7):685-693. PubMed ID: 38916092
[TBL] [Abstract][Full Text] [Related]
14. Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
Schmitz T; Freuer D; Goßlau Y; Warm TD; Hyhlik-Dürr A; Linseisen J; Meisinger C; Kirchberger I
Virus Res; 2024 Jun; 344():199363. PubMed ID: 38508399
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of COVID-19 in Ghana: symptomatology, illness severity and comorbid non-communicable diseases.
Oduro-Mensah E; Tetteh J; Adomako I; Adjei-Mensah E; Owoo C; Yawson AO; Oliver-Commey JA; Puplampu P; Samba A; Yawson AE; Lartey M;
Ghana Med J; 2020 Dec; 54(4 Suppl):23-32. PubMed ID: 33976438
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.
Li J; Chen Z; Nie Y; Ma Y; Guo Q; Dai X
J Med Internet Res; 2020 Jun; 22(6):e19636. PubMed ID: 32544071
[TBL] [Abstract][Full Text] [Related]
18. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
19. Post-acute sequelae of covid-19 six to 12 months after infection: population based study.
Peter RS; Nieters A; Kräusslich HG; Brockmann SO; Göpel S; Kindle G; Merle U; Steinacker JM; Rothenbacher D; Kern WV;
BMJ; 2022 Oct; 379():e071050. PubMed ID: 36229057
[TBL] [Abstract][Full Text] [Related]
20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
